What's breaking now, across thousands of outlets.
Bacteria in lung tumors may boost the activation of innate immune cells in the presence of a common vitamin metabolite, according to a preclinical study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
In this webinar, The post Is Targeted Protein Degradation the “Break” Neurology Needs? appeared first on GEN - Genetic Engineering and Biotechnology News .
A machine learning model can predict overactive bladder (OAB) risk in women using common reproductive and sociodemographic data, according to a study published online Aug.
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn.
Congo will receive 70,000 doses of the Ervebo vaccine, which has been effective in past Ebola outbreaks, the World Health Organization and partners said Thursday, announcing a step seen as a major…
Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.
Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.
